BMDM-derived ORP8 suppresses lipotoxicity and inflammation by relieving endoplasmic reticulum stress in mice with

Yi Chen1,2, Kangjie Xie3, Caiyang Chen1,2

  • 1Department of Anesthesiology, Renji Hospital, Jiaotong University School of Medicine, No. 160, Pujian Road, Pudong New District, Shanghai, 200217, China.

Abstract

Insights

Anti-inflammatory macrophage-derived extracellular vesicles (EVs) show therapeutic potential for metabolic dysfunction-associated steatohepatitis (MASH). These EVs, containing Osbpl8, reduce liver inflammation and lipotoxicity by modulating ER stress, offering a novel treatment strategy for MASH.

Area of Science:

  • Hepatology and Immunology
  • Cellular and Molecular Biology

Background:

  • Metabolic dysfunction-associated steatohepatitis (MASH) is a prevalent liver disease with limited treatment options.
  • Hepatic inflammation is a critical driver in the progression of MASH.
  • Anti-inflammatory macrophages play a role in maintaining immune homeostasis.

Purpose of the Study:

  • To elucidate the role of anti-inflammatory macrophages in MASH.
  • To investigate the underlying molecular mechanisms by which these macrophages influence MASH progression.

Main Methods:

  • Isolation and characterization of extracellular vesicles (EVs) from anti-inflammatory bone marrow-derived macrophages (BMDMs).
  • In vitro studies using palmitic acid-stimulated hepatocytes treated with EVs or Osbpl8 shRNA.
  • In vivo MASH model in C57BL/6 mice treated with EVs or shRNA-encoding AAV.

Main Results:

  • EVs from anti-inflammatory BMDMs inhibited inflammatory responses and alleviated lipotoxicity in MASH models.
  • Osbpl8 was identified as a key component in these EVs, remodeling lipid metabolism by reducing ER stress.
  • Osbpl8-enriched EVs demonstrated anti-inflammatory and anti-lipotoxic effects, suggesting therapeutic potential.

Conclusions:

  • Osbpl8 within EVs secreted by anti-inflammatory BMDMs is crucial for intercellular communication in MASH.
  • This study reveals a novel mechanism for macrophage homeostasis regulation in MASH.
  • Osbpl8-enriched EVs represent a promising therapeutic target for MASH treatment.